Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BIOV News

Recent news which mentions BIOV News

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Confirms First Clinical Site and Principal Investigators for Ovarian Cancer Vaccine Trial and Enters into Second Tumor Cell Supply Agreement
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Enters Critical Tumor Cell Supply Agreement with Deaconess Research Institute for BVX-0918 Bioproduction
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS ANNOUNCES MAJOR RESEARCH COLLABORATION WITH THE OHIO STATE UNIVERSITY TO DEVELOP BROADLY REACTIVE PAN-SARBECOVIRUS VACCINE
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys announces that CoviDTH Demonstrates Safety and Tolerability in Broad Ranging In Vivo Clinical Pathology, Immunology, and Histopathology Evaluation, Supporting Planned Clinical Development of
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS BEGINS TOXICITY STUDY AHEAD OF COVIDTH IND SUBMISSION
Tickers BIOV BVAXF NOTV
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS PREPARES FOR GROUND-BREAKING STUDY ON REDUCED ACE2 BINDING CAPABILITIES OF HAPTEN-MODIFIED SARS-COV-2 PROTEINS
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS CANCER VACCINE MANUFACTURING PARTNER BIO ELPIDA REACHES BIOPRODUCTION MILESTONE
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
BIOVAXYS BIOPRODUCTION PARTNER WUXI BIOLOGICS COMPLETES SYNTHESIS OF RECOMBINANT SARS-COV-2 S-PROTEINS FOR BVX-0320 AND CoviDTH PROGRAMS
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FURTHER STUDY IN HUMANS SHOWS THAT THE DTH RESPONSE, THE BASIS FOR CoviDTH, IS HIGHLY DURABLE AND PERSISTS FOR AT LEAST ONE YEAR AFTER COVID-19 EXPOSURE OR VACCINE ADMINISTRATION
Tickers BIOV BVAXF
Tags Featured News BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA PROVIDES NECESSARY GUIDANCE FOR BIOVAXYS TO BEGIN PREPARATION OF IND FOR PHASE I/II CLINICAL TRIALS OF CoviDTH
Tickers BIOV BVAXF
Tags BIOV News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.